trimetazidine has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chavez-Blanco, A; Correa-Basurto, J; Dominguez-Gomez, G; Duenas-Gonzalez, A; Garcia-Martinez, E; Gonzalez-Fierro, A; Romo-Perez, A; Taja-Chayeb, L | 1 |
| Kavtaradze, N; Saganelidze, K | 1 |
| Carstens, R; DeBerardinis, RJ; Hu, Z; Huffman, KE; Humphries, CG; Kittler, R; Kollipara, RK; Nguyen, H; Singh, DK; Srivastava, N; Sudderth, J; Wang, S | 1 |
1 review(s) available for trimetazidine and Neoplasms
| Article | Year |
|---|---|
[MODERN ASPECTS OF DIAGNOSIS AND TREATMENT OF HEART FAILURE, AS A MANIFESTATION OF ANTHRACYCLINE CARDIOTOXICITY (REVIEW)].
Topics: Anthracyclines; Antineoplastic Agents; Biomarkers; Cardiomyopathies; Cardiotonic Agents; Cardiotoxicity; Echocardiography; Elapid Venoms; Heart; Heart Failure; Humans; Ivabradine; Natriuretic Peptide, C-Type; Neoplasms; Survival Analysis; Trastuzumab; Trimetazidine; Troponin I | 2018 |
2 other study(ies) available for trimetazidine and Neoplasms
| Article | Year |
|---|---|
BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal.
Topics: Apomorphine; Benserazide; Drug Combinations; Humans; Neoplasms; Pantoprazole; Simvastatin; Trimetazidine | 2022 |
Inhibition of cancer cell proliferation by PPARĪ³ is mediated by a metabolic switch that increases reactive oxygen species levels.
Topics: Animals; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Fatty Acids; Humans; Lipid Peroxidation; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms; Phosphorylation; Pioglitazone; PPAR gamma; Protein Interaction Maps; Protein Kinases; Reactive Oxygen Species; Retinoblastoma Protein; Thiazolidinediones; Transplantation, Heterologous; Trimetazidine | 2014 |